RBC Capital Sees $191 For Allergen (AGN) In A Growth/MatureCo Breakup

June 19, 2019 7:31 AM EDT Send to a Friend
RBC Capital analyst Randall Stanicky reiterated a Sector Perform rating and $140.00 price target on Allergen (NYSE: AGN) after shares ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login